Welcome to our dedicated page for Ventas news (Ticker: VTR), a resource for investors and traders seeking the latest updates and insights on Ventas stock.
Ventas, Inc. is an S&P 500 real estate investment trust with a healthcare and senior housing property portfolio in North America and the United Kingdom. News about VTR commonly covers quarterly results, senior housing operating portfolio performance, occupancy and RevPOR trends, net operating income, healthcare real estate investments, dividends and tax treatment of distributions.
Company updates also address investor presentations, earnings calls, capital allocation and portfolio categories that include senior housing communities, outpatient medical buildings, research centers and healthcare facilities.
Ventas, Inc. (NYSE: VTR) reported its fourth quarter and full year 2022 results, highlighting a net loss of ($0.11) per share and a year-over-year NOI growth of 7.5%. Normalized Funds from Operations (FFO) per share remained stable at $0.73. The company saw a significant 19.1% growth in same-store cash NOI driven by strong performance in its SHOP portfolio. Notably, Ventas earned its first promote revenue approximating $0.02 per share from its third-party investment management business. The company committed $1.2 billion in investments throughout 2022, with substantial projects emphasizing life sciences and senior housing. Finally, Ventas has a robust liquidity position with $2.4 billion available for future investments.
Ventas, Inc. (NYSE: VTR) has appointed J. Justin Hutchens as Chief Investment Officer while retaining his role as Executive Vice President of Senior Housing. This dual role aims to enhance capital allocation and streamline management, with Hutchens overseeing both Senior Housing and Investments teams. Hutchens, with over 25 years of experience, has successfully led Ventas’s Senior Housing business since 2020, managing nearly half of the company's portfolio. He succeeds John D. Cobb, who will transition to a strategic advisor role. This management change is viewed as a strategic move to bolster operational and investment strategies.
Ventas, Inc. (NYSE: VTR) will release its Q4 2022 earnings on February 9, 2023, after NYSE trading closes. A conference call for discussing these results is scheduled for February 10, 2023, at 10:00 a.m. ET. Interested parties can join via dial-in at (888) 330-3576 or +1 (646) 960-0672 for international access. The webcast will be available on the company's Investor Relations page. Ventas, a leading real estate investment trust, maintains a diversified portfolio exceeding 1,200 properties across the U.S., Canada, and the U.K., focusing on healthcare-related real estate.
Ventas, Inc. (NYSE: VTR) announced the tax treatment of its 2022 common stock distributions, totaling $1.80 per share. This includes a $0.45 dividend paid on January 19, 2022. The fourth quarter dividend declared on December 7, 2022 will be taxable in 2023. Shareholders are advised to consult their tax advisors regarding tax implications. Ventas operates in healthcare and real estate, owning over 1,200 properties across the U.S., Canada, and the U.K., benefiting from the aging population trend.
Ardent Health Services has partnered with SwitchPoint Ventures to establish an innovation studio aimed at transforming healthcare delivery. Building on a successful two-year collaboration, the studio will develop data-driven solutions across Ardent’s 30 hospitals and 200 care sites. Key projects include Winnow for clinician recruitment and Polaris to predict patient volumes, enhancing operational efficiency. The partnership signifies a commitment to addressing critical issues in healthcare, with plans for independent ventures catering to the broader industry.
Cadence has announced a partnership with Ardent Health Services to implement a remote patient monitoring program across Ardent's network of 30 hospitals and 200 care sites in six states. This program focuses on improving patient outcomes, reducing Medicare spending, and enhancing care delivery, particularly for patients with chronic conditions such as hypertension and diabetes. The partnership aims to alleviate burdens on clinicians and offers personalized care by monitoring patients' vitals daily. Initial rollout began at Utica Park Clinic in Tulsa, Oklahoma, with expansion planned over the next year.
Ardent Health Services has appointed Dr. Brad Hoyt as the new Chief Medical Information Officer (CMIO). With nearly 30 years of clinical expertise, Dr. Hoyt will optimize electronic health records and lead tech-enabled improvements across Ardent's 30 hospitals and 200 sites. Under his leadership, Ardent aims to enhance clinical performance, evidenced by achieving Level 9 in the Epic Gold Star Program. This move reflects Ardent's commitment to leveraging data to improve healthcare outcomes and workflows.
Signify Health expands its relationship with Ardent Health Services as Ardent transitions from the BPCI-A program to a Signify-supported accountable care organization (ACO) in 2023.
The collaboration aims to manage risk and deliver high-quality care for Medicare patients, aligning with CMS goals for accountable care.
Notably, Ardent has achieved a 26% reduction in 90-day readmission rates, enhancing patient outcomes. This partnership also follows Signify's acquisition of Caravan Health, bolstering its ACO capabilities, with participants historically earning shared savings.
HealthTrust Performance Group and Ardent Health Services have renewed their long-term partnership for supply chain management and group purchasing. This new ten-year agreement ensures Ardent providers have access to favorable pricing and contracting across a wide range of healthcare supplies. Ardent operates 30 hospitals and nearly 200 non-acute care sites, handling over 2.7 million patient encounters annually. Both organizations emphasized the importance of sustainability in supply services amid recent supply chain disruptions.
Ventas, Inc. (NYSE: VTR) has declared a quarterly dividend of $0.45 per common share, payable on January 19, 2023, to shareholders recorded by the close of business on January 3, 2023. Ventas operates over 1,200 properties across the U.S., Canada, and the U.K., focusing on healthcare real estate driven by demographic demand. With over 20 years of a successful, diversified strategy, Ventas emphasizes financial strength, reliable growth, and significant ESG achievements.